Endometriosis Drugs Market Share,Trends,Supply,Sales,Key Players,Demand and Forecast 2020

WiseGuyReports.Com Publish a New Market Research Report On –“ Endometriosis Drugs Market Share,Trends,Supply,Sales,Key Players,Demand and Forecast 2020”.


The analysts forecast the global endometriosis market to grow at a CAGR of 2.05% during the period 2016-2020.

Endometriosis is a common health condition in women where the endometrial tissue, which is found in the lining of the uterus, appears and grows outside the uterine cavity. The endometrial tissue is shed from the body during menstruation.
The tissue growing outside the uterine cavity is called endometrial implants. Endometriosis can also occur in the fallopian tubes, ovaries, pelvic cavity, vagina, cervix, and bladder. In rare cases, it has been reported in other parts of the body such as the lungs, brain, and skin. These implants are usually benign in nature. Women of reproductive age are often affected by this condition.
Endometriosis often occurs due to retrograde menstruation, where the menstrual blood flows back into the pelvic cavity instead of leaving the body. This then adheres to the surface of the bladder, ovaries, or rectum and continues to grow or thicken over the course of each menstrual cycle.


Get a Sample Report @    https://www.wiseguyreports.com/sample-request/543710-global-endometriosis-drugs-market-2016-2020

For more information or any query mail at sales@wiseguyreports.com


Covered in this report
The report covers the present scenario and the growth prospects of the global endometriosis market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of approved and off-label branded and generic drugs used for the treatment and prevention of endometriosis and related pain. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
• Americas

The report, Global Endometriosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• AbbVie
• AstraZeneca
• Bayer HealthCare
• Pfizer

Other prominent vendors
• Addex Therapeutics
• Astellas Pharma
• Debiopharm
• ElexoPharm
• Endoceutics
• Euroscreen
• Forendo Pharma
• Isifer
• Kissei Pharmaceutical
• Neurocrine Biosciences
• Nippon Shinyaku
• ObsEva
• Orphagen Pharmaceuticals
• Philogen
• PregLem
• Repros Therapeutics
• Roivant Sciences
• SK Chemicals
• Speciality European Pharma
• SYNG Pharmaceuticals
• Takeda
• United Pharmaceuticals
• ValiPharma

Market driver
• Increased adoption of OCPs
• For a full, detailed list, view our report

Market challenge
• Surgeries as primary treatment option
• For a full, detailed list, view our report

Market trend
• Increased focus on intrauterine devices (IUDs)
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Report Details @   https://www.wiseguyreports.com/reports/543710-global-endometriosis-drugs-market-2016-2020


Table Of Contents – Major Key Points

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights
  • Endometriosis: An overview

PART 05: Pipeline analysis

  • Pipeline molecules based on their mechanism

PART 06: Key buying criteria for endometriosis drugs

PART 07: Market landscape

  • Market overview
  • Five forces analysis

PART 08: Market segmentation by type of therapy

  • Hormone therapy
  • Market size and forecast
  • Pain medications
  • Market size and forecast

PART 09: Market segmentation by ROA

  • Oral
  • Parenteral
  • Intrauterine systems
  • Nasal spray

PART 10: Geographical segmentation

  • Global endometriosis drugs market by geography 2015-2020
  • Endometriosis drugs market in Americas
  • Endometriosis drugs market in EMEA
  • Endometriosis drugs market in APAC

PART 11: Market drivers

  • Recurrence of endometriosis
  • Increased adoption on OCPs
  • Ineffective existing therapies leading to high unmet need

PART 12: Impact of drivers

PART 13: Market challenges

  • Poor compliance rates leading to high dropouts
  • Surgeries as primary treatment option
  • Unavailability of proper diagnostic tools


For more information or any query mail at sales@wiseguyreports.com



Partner Relations & Marketing Manager



Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.